Print

Print


There is real, concrete, you can smell/feel/see kind of evidence....


From the Archives -- WSJ Interactive Edition



                  April 13, 1999

            Stem Cells From Adults
            Have an Edge Battling Disease
            By LAURA JOHANNES
            Staff Reporter of THE WALL STREET JOURNAL

            The isolation of stem cells from an aborted fetus a few
months ago
            sparked great excitement among scientists. Some of them
speculated
            that the embryonic cells were a kind of miraculous clay
that, given
            the proper nudge, could be turned into any type of human
cell -- and
            even entire organs.
            But a humbler type of stem cell may prove much more useful
to
            medical science. Unlike the embryonic cell, this type,
called a
            "precursor" cell, has already had its fate broadly
determined. For
            example, scientists have discovered a blood precursor cell
that can
            become any type of blood cell --say, a white cell or red
cell -- but
            never a skin or bone cell.
            While precursor cells' morphing potential is narrower,
many
            scientists believe that turning them into medical
treatments will be
            much easier, because they are further along in their
development.
            That opens up a whole world of potential injectable
therapies that
            would harness the body's capacity to regenerate itself.
            "If you're trying to travel from Boston to San Francisco,
this would
            be the equivalent of starting in Des Moines instead of
Boston," says
            Mitchell J. Weiss, a senior scientist at Ontogeny Inc., of
            Cambridge, Mass. Ontogeny is working with Biogen Inc. to
activate
            precursor cells that it believes are in the brain in an
effort to
            regenerate brain cells lost in Parkinson's disease.
            Scientists used to think that such potential for cellular
            regeneration was present only in embryos -- that, for
example,
            humans had made their lifetime supply of brain cells by
age 17.
            But that canon is steadily eroding. In the early 1990s,
researchers
            isolated human blood stem cells from adults. And earlier
this month,
            researchers at Osiris Therapeutics Inc. in Baltimore found
a stem
            cell in adult bone marrow that is capable of becoming
bone,
            cartilage or fat. Researchers also believe they may be
close to
            identifying stem cells in the liver, brain and pancreas.
            They're Everywhere
            "I think we will find these stem cells in any organ that
we look,"
            says Harvard Medical School researcher Evan Y. Snyder, who
has
            already isolated brain stem cells from a human fetus and
believes it
            won't be long before someone finds them in adult humans.
"I think
            that when nature develops a strategy for development and a
strategy
            for self-repair, it doesn't make it up each time for every
organ."
            Some scientists remain skeptical that stem cells will be
found in
            every organ. And hunting is a laborious process. Brain
stem cells
            were found in animals a decade ago, but scientists are
still working
            to find them in humans. But if and when they are found,
precursor
            cells would circumvent the ethical and legal problems of
working
            with embryonic stem cells taken from aborted fetuses.
            Douglas A. Melton, chairman of the department of molecular
and cell
            biology at Harvard University, has found promising results
in mouse
            and frog stem cells but hasn't been able to obtain human
embryonic
            cells to apply the work to humans.
            The National Institutes of Health has said it will permit
federally
            funded researchers to use stem cells as long as they don't
actually
            handle aborted fetuses, but the cells won't be available
until
            formal guidelines for their use have been published.
Meanwhile, work
            with the stem cells found in adults is moving along
rapidly.
            In early clinical trials in the area of AIDS, Novartis AG
is
            purifying blood stem cells from HIV patients' own blood,
altering
            them by inserting anti-HIV genes and then reinjecting them
in the
            patients. "We expect the modified stem cells will give
rise to
            progeny cells that are HIV-resistant," says Carol
Grundfest, a
            Novartis spokeswoman.




Margaret Tuchman
Princeton, NJ
B1941/Dx1980
[log in to unmask]